Increased depression risk among patients with chronic osteomyelitis.

Area of Science:

• Neuroscience
• Psychiatry
• Epidemiology

Background:

• Inflammation influences brain neurotransmitter metabolism, neuroendocrine function, and neuroplasticity, potentially contributing to depression.
• In individuals without traditional risk factors, inflammation is a likely driver of depression, particularly in younger populations.
• Chronic osteomyelitis (COM) is a persistent inflammatory condition with unknown links to mental health outcomes.

Purpose of the Study:

• To investigate the association between chronic osteomyelitis (COM) and the risk of developing depression.
• To determine if COM serves as an independent risk factor for depression.
• To identify specific demographic groups with elevated depression risk in the context of COM.

Main Methods:

• Utilized a Taiwanese national insurance claims database exceeding 22 million enrollees.
• Selected 15,529 COM patients without prior depression history and 62,116 matched controls.
• Employed Cox proportional hazards regression to analyze depression development over a 12-year follow-up period (1999-2010).

Main Results:

• The COM cohort demonstrated a significantly higher risk of depression compared to controls (HR=3.04, 95% CI: 2.55-3.62).
• Even when excluding comorbidities, COM patients showed increased depression risk.
• Younger individuals (<45 years) with COM exhibited a substantially greater risk (HR=6.08, 95% CI: 1.71-7.85).

Conclusions:

• This study establishes the first link between chronic osteomyelitis (COM) and an elevated risk of depression.
• COM is identified as a significant predictor of depression.
• Highlights the need for enhanced depression screening and prevention in COM patients, with a particular focus on younger demographics.